by Stacey Johnson | Oct 16, 2020
The news that Health Canada has approved gene therapy Luxturna to treat blindness couldn’t come at a better time, as October is Blindness Awareness Month. You don’t have to look far to find other high impact research on blindness happening right here in Toronto,...
by Stacey Johnson | Jul 24, 2020
When you hear the term “playing God” does it make you think of science? I will wager yes and that you connect the two even more after watching the docuseries “Unnatural Selection” on Netflix. I watched it for the purposes of this blog, but quickly became engrossed in...
by David Kent | May 21, 2020
Over the past four weeks, I’ve discussed numerous aspects of gene therapy in an attempt to convey my excitement for this field moving forward. The convergence of numerous advances in basic biology (as described here and here) and clinical trials (as explained here and...
by David Kent | May 14, 2020
The second post in this series on gene therapy and blood stem cells might give readers a small sense of the absolutely enormous research investment (time, money, people, etc.) required to find a way to expand blood stem cells for therapeutic purposes. Ever since the...
by David Kent | May 6, 2020
As mentioned in the introductory post to this series on blood stem cell gene therapy, several significant issues existed with the first set of clinical trials in the gene therapy world. It became abundantly clear that simply delivering the gene target on its own would...
Comments